Bliss GVS Pharma (NSE:BLISSGVS) Total Liabilities : ₹2,090 Mil (As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Bliss GVS Pharma Total Liabilities?

Bliss GVS Pharma's Total Liabilities for the quarter that ended in Mar. 2025 was ₹2,090 Mil.

Bliss GVS Pharma's quarterly Total Liabilities declined from Sep. 2024 (₹2,344.65 Mil) to Dec. 2024 (₹0.00 Mil) but then increased from Dec. 2024 (₹0.00 Mil) to Mar. 2025 (₹2,089.92 Mil).

Bliss GVS Pharma's annual Total Liabilities declined from Mar. 2023 (₹2,394.29 Mil) to Mar. 2024 (₹2,108.85 Mil) and declined from Mar. 2024 (₹2,108.85 Mil) to Mar. 2025 (₹2,089.92 Mil).

Bliss GVS Pharma Total Liabilities Historical Data

The historical data trend for Bliss GVS Pharma's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bliss GVS Pharma Total Liabilities Chart

Bliss GVS Pharma Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Total Liabilities

Get a 7-Day Free Trial

2,488.76

2,622.85

2,394.29

2,108.85

2,089.92

Bliss GVS Pharma Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															2,108.85	-	2,344.65	-	2,089.92

Bliss GVS Pharma Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Bliss GVS Pharma's Total Liabilities for the fiscal year that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1717.17	+	(325.649	+	47.105
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	2,090

Total Liabilities	=	Total Assets (A: Mar. 2025 )	-	Total Equity (A: Mar. 2025 )
	=	13008.389	-	10918.465
	=	2,090

Bliss GVS Pharma's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1717.17	+	(325.649	+	47.105
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	2,090

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	13008.389	-	10918.465
	=	2,090

Bliss GVS Pharma Total Liabilities Related Terms

Thank you for viewing the detailed overview of Bliss GVS Pharma's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Bliss GVS Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bliss GVS Pharma Ltd (NSE:BLISSGVS) » Definitions » Total Liabilities

Traded in Other Exchanges

506197:India

Address

Saki Vihar Road, 102, Hyde Park, Andheri (East), Mumbai, MH, IND, 400072

Website

https://www.blissgvs.com

Bliss GVS Pharma Ltd is an India-based company engaged in the manufacturing, marketing, trading, and export of pharmaceutical products. Some of its brands include Lonart, P-Alaxin, Funbact, and Lofnac, and others. It offers pharma products including tablets, suspensions, suppositories, and injections. The majority of its revenue is derived from exports.

Bliss GVS Pharma Headlines

No Headlines